Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998. 2003

Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
Department of Virology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.

Measles is an acute highly infectious viral disease. Although live attenuated vaccine is used throughout the world, outbreaks of disease still occur in many countries including Iran. In this cross-sectional study, by implementing a viral neutralization test and cell culture techniques, the seroprevalence of neutralizing anti-measles antibodies was assessed. Three hundred and fifty-four blood samples were collected and random-cluster classified from healthy subjects 6 months to 16 years old, residing in the town of Khodabandeh and its rural areas. Of the total subjects, 174 (49.2%) were girls and 180 (50.8%) were boys. From 354 subjects studied, 310 (87.6%) had neutralizing anti-measles antibody titer of 1:8 or higher and were considered to be immune and 44 (12.4%) had lower antibody titers. At the time of specimen collection, information with regards to age, sex, history of vaccination and place of residence were collected. Chi2 statistical test demonstrated a significant association between immune status and grouped age at the time of first vaccination (p < 0.009). The proportion test indicated significant differences in rate of seropositivity in paired age groups (3-8 vs. 9-11 and 9-11 vs. 12-64 months) (p < 0.02). The use of reliable techniques for assessing success of vaccination programs and performing seroepidemiological studies in order to organize national programs of control and eradication of measles are necessary.

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007223 Infant A child between 1 and 23 months of age. Infants
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional

Related Publications

Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
November 2022, Vaccines,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
January 1965, Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
January 2019, Central-European journal of immunology,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
September 2006, The Journal of infectious diseases,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
January 1999, MMWR. Morbidity and mortality weekly report,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
March 1979, Journal of the neurological sciences,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
November 2008, The American journal of tropical medicine and hygiene,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
January 2005, International journal of adolescent medicine and health,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
April 1988, Danish medical bulletin,
Mazaher Khodabandeh Loo, and Farzaneh Sabahi, and Horieh Soleimanjdahi, and Anooshirvan Kazemnejad, and Mohammod Hassan Roustai
March 2003, Journal of virology,
Copied contents to your clipboard!